Clinical Roundup Keytruda combination improves OS for HER2-positive advanced gastric cancer in phase III trial May 03, 2024Vol.50 No.18
Clinical Roundup Enhertu improves PFS in HR-positive, HER2-low breast cancer in phase III trial May 03, 2024Vol.50 No.18
Clinical Roundup Glecirasib shows positive ORR for KRASG12C mutated-NSCLC in phase II trial May 03, 2024Vol.50 No.18
Clinical Roundup Breast cancer screening tool predicts patient response to immunotherapies May 03, 2024Vol.50 No.18
Clinical Roundup One-tube test could expand cervical cancer screening, speed diagnosis May 03, 2024Vol.50 No.18
Clinical Roundup APC activation, CDK inactivation triggers “doubling” in cancer cell division May 03, 2024Vol.50 No.18
Clinical Roundup PRMT5 inhibitor combination overcomes drug resistance in ER+ breast cancer April 26, 2024Vol.50 No.17
Clinical Roundup HER2-CAR T-cell therapy induces antitumor activity in high-risk sarcomas in phase I trial April 26, 2024Vol.50 No.17
Clinical Roundup Catuvab device removes malignant cells from intraoperative blood salvage procedures April 26, 2024Vol.50 No.17
